PHM vs PPCB · P/E 7.7, rev $17.95B vs P/E 0.0, $3.9M cap
PulteGroup Inc (PHM) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
PPCB does not have a complete income-statement cache yet.
PHM currently screens at market cap $21.92B and trailing P/E 7.7. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the PHM and PPCB stock pages for the full models.
Not investment advice.